Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
MAPK11 (p38β) is a major determinant of cellular radiosensitivity by controlling ionizing radiation-associated senescence: An in vitro study.
Fernández-Aroca DM, García-Flores N, Frost S, Jiménez-Suárez J, Rodríguez-González A, Fernández-Aroca P, Sabater S, Andrés I, Garnés-García C, Belandia B, Cimas FJ, Villar D, Ruiz-Hidalgo MJ, Sánchez-Prieto R. Fernández-Aroca DM, et al. Among authors: ruiz hidalgo mj. Clin Transl Radiat Oncol. 2023 Jun 2;41:100649. doi: 10.1016/j.ctro.2023.100649. eCollection 2023 Jul. Clin Transl Radiat Oncol. 2023. PMID: 37346275 Free PMC article.
p38β (MAPK11) mediates gemcitabine-associated radiosensitivity in sarcoma experimental models.
Pascual-Serra R, Fernández-Aroca DM, Sabater S, Roche O, Andrés I, Ortega-Muelas M, Arconada-Luque E, Garcia-Flores N, Bossi G, Belandia B, Ruiz-Hidalgo MJ, Sánchez-Prieto R. Pascual-Serra R, et al. Among authors: ruiz hidalgo mj. Radiother Oncol. 2021 Mar;156:136-144. doi: 10.1016/j.radonc.2020.12.008. Epub 2020 Dec 11. Radiother Oncol. 2021. PMID: 33310004
Effect of the aniline fragment in Pt(II) and Pt(IV) complexes as anti-proliferative agents. Standard reduction potential as a more reliable parameter for Pt(IV) compounds than peak reduction potential.
Leal J, Santos L, Fernández-Aroca DM, Cuevas JV, Martínez MA, Massaguer A, Jalón FA, Ruiz-Hidalgo MJ, Sánchez-Prieto R, Rodríguez AM, Castañeda G, Durá G, Carrión MC, Barrabés S, Manzano BR. Leal J, et al. Among authors: ruiz hidalgo mj. J Inorg Biochem. 2021 May;218:111403. doi: 10.1016/j.jinorgbio.2021.111403. Epub 2021 Mar 9. J Inorg Biochem. 2021. PMID: 33730639
The CDK12-BRCA1 signaling axis mediates dinaciclib-associated radiosensitivity through p53-mediated cellular senescence.
Flores NG, Fernández-Aroca DM, Garnés-García C, Domínguez-Calvo A, Jiménez-Suárez J, Sabater S, Fernández-Aroca P, Andrés I, Cimas FJ, de Cárcer G, Belandia B, Palmero I, Huertas P, Ruiz-Hidalgo MJ, Sánchez-Prieto R. Flores NG, et al. Among authors: ruiz hidalgo mj. Mol Oncol. 2024 Dec 3. doi: 10.1002/1878-0261.13773. Online ahead of print. Mol Oncol. 2024. PMID: 39626031 Free article.
Ferrozoles: Ferrocenyl derivatives of letrozole with dual effects as potent aromatase inhibitors and cytostatic agents.
Diaz de Greñu B, Fernández-Aroca DM, Organero JA, Durá G, Jalón FA, Sánchez-Prieto R, Ruiz-Hidalgo MJ, Rodríguez AM, Santos L, Albasanz JL, Manzano BR. Diaz de Greñu B, et al. Among authors: ruiz hidalgo mj. J Biol Inorg Chem. 2023 Sep;28(6):531-547. doi: 10.1007/s00775-023-02006-0. Epub 2023 Jul 17. J Biol Inorg Chem. 2023. PMID: 37458856
Etiopathogenic role of ERK5 signaling in sarcoma: prognostic and therapeutic implications.
Sánchez-Fdez A, Matilla-Almazán S, Del Carmen S, Abad M, Arconada-Luque E, Jiménez-Suárez J, Chinchilla-Tábora LM, Ruíz-Hidalgo MJ, Sánchez-Prieto R, Pandiella A, Esparís-Ogando A. Sánchez-Fdez A, et al. Among authors: ruiz hidalgo mj. Exp Mol Med. 2023 Jun;55(6):1247-1257. doi: 10.1038/s12276-023-01008-x. Epub 2023 Jun 19. Exp Mol Med. 2023. PMID: 37332046 Free PMC article.
P38 MAPK and Radiotherapy: Foes or Friends?
García-Flores N, Jiménez-Suárez J, Garnés-García C, Fernández-Aroca DM, Sabater S, Andrés I, Fernández-Aramburo A, Ruiz-Hidalgo MJ, Belandia B, Sanchez-Prieto R, Cimas FJ. García-Flores N, et al. Among authors: ruiz hidalgo mj. Cancers (Basel). 2023 Jan 30;15(3):861. doi: 10.3390/cancers15030861. Cancers (Basel). 2023. PMID: 36765819 Free PMC article. Review.
ERK5 Is a Major Determinant of Chemical Sarcomagenesis: Implications in Human Pathology.
Arconada-Luque E, Jiménez-Suarez J, Pascual-Serra R, Nam-Cha SH, Moline T, Cimas FJ, Fliquete G, Ortega-Muelas M, Roche O, Fernández-Aroca DM, Muñoz Velasco R, García-Flores N, Garnés-García C, Sánchez-Fdez A, Matilla-Almazán S, Sánchez-Arévalo Lobo VJ, Hernández-Losa J, Belandia B, Pandiella A, Esparís-Ogando A, Ramón Y Cajal S, Del Peso L, Sánchez-Prieto R, Ruiz-Hidalgo MJ. Arconada-Luque E, et al. Among authors: ruiz hidalgo mj. Cancers (Basel). 2022 Jul 19;14(14):3509. doi: 10.3390/cancers14143509. Cancers (Basel). 2022. PMID: 35884568 Free PMC article.
39 results